Pharmaceutical and healthcare companies are highly dedicated in giving the utmost service and product pipelines to its ventures. These companies are merged together in order to deliver the demands. Mentioning one of the key players in the pharmaceutical and medical industry is the C.R. Bard, Inc.

C. R. Bard, Inc., (Bard C.R. Inc) recently shortened to Bard, headquartered in their main office in Murray Hill, New Jersey, USA and medical locations around the world, is one of the leaders in developing, manufacturing, and marketing of medical technologies in the following medical fields or specialties: vascular, urology, oncology, and surgical specialties. It creates their dedicated access system, peripheral vascular products, medical supplies and devices in pharmaceuticals. In April 2017, an announcement was done by Bard that it will be acquired by Becton Dickinson.

R. Bard, Inc. Headquarters Address

Contacts

• Mailing address: 730 Central Avenue, Murray Hill, NJ 07974, USA
• Contact number: 908-277-8000
• Website: www.crbard.com
• Employee email: TS.ServiceDesk@crbard.com
• Subsidiaries
  1. Bard Medical Div.
  2. Davol Inc.
  3. Bard Int’l
  4. Venetec Int’l, Inc.

Key People/Executives for C. R. Bard, Inc.

C. R. Bard, Inc. Profile/Overview

C. R. Bard, Inc. was founded in NYC by a man named Charles R. Bard in 1907. The first venture involved importing the medicine Gomenol, which was used to treat urinary discomfort. Formal incorporation was done in 1923, and three years later, in 1926, Charles let the company be sold to John F. Willits and Edson L. Outwin for $18,000. Under Willits and Outwins, expansion was done into the catheter business, introducing the Foley catheter in 1934 and the America Woven Catheter in 1940.

In 1948, Bard’s yearly sales totalled $1 million for the first time ever, and the company moved its headquarters from New York City to Summit, New Jersey. In 1954, Dr. DeBakey, a scientist from the company, developed the first arterial prosthesis. Three years later the selling Foley catheters that came in sterile packaging was done by Bard for the first time. Furthermore it continued its actions to innovate in the world of catheters, rolling out the Bipolar Temporary Pacing catheter in 1958 and the first latex balloon catheter in 1960. In 1961, expansions were done and began manufacturing products related to cardiology, radiology, and anesthesiology.

IPO was done by Bard in 1963 and was listed on the New York Stock Exchange in the year of 1968. Introduction of variety of new health care products was commenced by the company since that time. Its net sales reached to an amount of over $1 billion. Around the year of 2012, Bard made an acquisition to the company Lutonix.
On April 23, 2017, announcement was done that Becton Dickinson would acquire them for $24 billion.

C. R. Bard, Inc. Products/Capabilities

• C. R. Bard, Inc., together with its merged companies and subsidiaries, is dedicated in designing, manufacturing, packaging, distributing, and selling medical, surgical, diagnostic, and patient care devices internationally. The company offers the following:
  1. Vascular products, such as, chronic total occlusion catheters, guidewires, percutaneous transluminal angioplasty, cathetersfabrics, meshes, introducers, and accessories
  2. Valvuloplasty balloons; peripheral vascular stents, self-expanding and balloon-expandable covered stents, and vascular grafts; vena cava filters
  3. Biopsy devices; and a range of minimally invasive devices for the treatment of peripheral vascular and end-stage renal diseases
  4. Urology products, including foley catheters to reduce the rate of urinary tract infections
  5. Fecal incontinence products
  6. Brachytherapy devices and radioactive seeds for the treatment of prostate cancer
  7. Intermittent urinary drainage catheters, and urine monitoring and collection systems
  8. Ureteral stents
  9. Specialty devices for stone removal procedures
  10. Surgical slings and pelvic floor repair products
  11. Catheter stabilization devices; and products for therapeutic hypothermia.
  12. Oncology products, such as specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters, and enteral feeding devices to treat and manage various cancers, and other diseases and disorders
  13. Surgical specialty products comprising implanted grafts and fixation devices for hernia and soft tissue repairs
  14. Hemostats and surgical sealants, as well as irrigation, wound drainage, and original equipment manufacturers products.

Devices in the medical world are made in quality to its customers and potential ventures. Such companies dedicated to make these are integrated in order to deliver the demands. Mentioning one of the key players in this industry is the Boston Scientific Corporation.

Boston Scientific Corporation (known as Boston Scientific) is a corporate international leader in the development, manufacturing and marketing of medical devices which showcases products in the range of interventional medical specialties, including the following medical disciplines: interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. They are also known in developing diabetes products.

Boston Scientific Corporation Headquarters Address

Contact

• Mailing address: 300 Boston Scientific Way, Marlborough, MA 01752, USA
• Boston Scientific Japan: Nikko Building,1-14-11 Nishi Shinjuku, Shinjuku-ku, Tokyo,  160-0023, Japan
• Phone number: 508-683-4000
• Website: www.bostonscientific.com

Subsidiaries

• Guidant
• Cameron Health
• Symetis SA
• Target Therapeutics Inc.
• Cardiac Pacemakers, Inc.

Key People/Executives for Boston Scientific Corporation

Boston Scientific Corporation Profile/Overview

• Forming of the BSC was done on June 29, 1979 as a holding company for a medical products company called Medi-Tech, and to position the company for growth in interventional medicine. IPO was made by the company on May 19, 1992.
  Approval to The Taxus Stent was made in 2003 in Europe and other countries and approved in the United States by the FDA in March 2004. It was considered as the second drug-eluting stent approved in the USA.
• On April 21, 2006, the company made an acquisition to their longtime competitor Guidant for $27.2 billion. It was then split between BSC and Abbott Laboratories.
• Forming of Navilyst Medical was done in February 2008 from Boston Scientific’s Fluid Management and Vascular Access business units.

Boston Scientific Corporation Products/Capabilities

Boston Scientific Corporation is highly dedicated in developing, manufacturing, and marketing medical devices for use in various interventional medical specialties internationally. It operates through three segments:

1. Cardiovascular
2. Rhythm Management
3. MedSurg

The company offers the following products:

1. Interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease
2. Other coronary therapy products to treat atherosclerosis
3. Intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels
4. Structural heart therapy systems
5. Stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters used to treat peripheral arterial disease
6. Biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease benign and malignant tumors.
7. Cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms
8. Implantable cardiac resynchronization therapy pacemaker systems used to treat heart failure
9. Medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising steerable radio frequency ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories
10. Products to diagnose and treat diseases of the pulmonary and gastrointestinal conditions
11. Devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs
12. Products to treat urinary stone disease and benign prostatic hyperplasia
13. Mid-urethral sling products, sling and graft materials, pelvic floor reconstruction kits, and suturing devices
14. And spinal cord stimulator systems for the management of chronic pain

Medical equipment are made to dedicate them to potential customers and firms. Certain creations and acquisitions are being made especially in the health care and their corresponding human resources. Mentioning one of the key players in this industry is the Becton, Dickinson and Company.

Becton, Dickinson and Company (BD) is a MedTech corporation based in the United States that makes and sells medical devices, instrument systems, and other related products. Founded in 1897 and corporate in Franklin Lakes, New Jersey, the company has 50,000 people working in more than 50 locations in countries internationally. In fiscal year ending of September 30, 2009, more than half of BD sales were generated from non-U.S. markets.

Becton, Dickinson and Company Headquarters Address

Contact

• Address location: #1 Becton Drive, Franklin Lakes, NJ 07417, U.S.A.
• Phone number: 201-847-6800
• Website: http://www.bd.com

Subsidiaries

• CareFusion
• Accuri Cytometers Inc.
• PharMingen
• Becton Dickinson A
• Becton Dickinson and more.

Key People/Executives for Becton, Dickinson and Company

Becton, Dickinson and Company Profile/Overview

• Maxwell W. Becton and Fairleigh S. Dickinson were the proponents of the company in 1897, two American businessmen who met on a sales trip. In the same year of first sales, a Luer-all-glass syringe that sold for an amount of $2.50. In 1898, the first patent for a medical product was acquired. In 1899 initial design of logo was created in which was meant to symbolize guaranteed superior quality of the products provided by the company.
• In 1948, the next generation of Fairleigh S. Dickinson, Jr. and Henry P. Becton, sons of the founders, led the BD. Their term was a time of rapid development for BD. The company generally grew within the U.S. as well as internationally.
• In 1973, another U.S. facility was added by BD—a research center in Durham, North Carolina in Research Triangle Park. It was built to help meet United States Environmental Protection Agency (EPA) requirements, research improved manufacturing and process methods, and develop future innovative technologies.
• In 1999, as BD exists for more than a century, it was announced that BD has its new corporate identity. Later then it was shortened to BD.
• The notable year of ’06 was to document BD’s growth as the acquisition was done to GeneOhm Sciences—a leader in the development of molecular diagnostic testing for the rapid detection of bacterial organisms and TriPath Imaging—a cancer diagnostics company.

Becton, Dickinson and Company Products/Capabilities

Becton, Dickinson and Company is dedicated to bring medical products internationally. It operates in two segments. They are:

1. BD Medical – This segment offers products such as syringes, pen needles, and IV sets for diabetes; and intravenous catheters for medication delivery of needles, syringes,; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; intravenous medication safety and infusion therapy delivery.
2. BD Life Sciences – The BD Life Sciences segment provides systems for specimen acquisition processes; safety-engineered blood collection, automated blood culturing and tuberculosis culturing, and microorganism identification and drug susceptibility systems; tests for molecular specimen systems for infectious diseases and women’s health; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation, and plated media products.

There is a steadily-increasing demand for equipment in the medical industry. Certain firms are clamouring for more. One of the most recognized companies out there is the Baxter International Inc.

Baxter International Inc. is an international medical company that is listed in the Fortune 500 with locations and stocks around the world. Based on their corporate office in Deerfield US, it mainly focuses on healthcare and products to treat various diseases and inflammations such as hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions. The company had overall sales in 2013 of $16.3 billion, across two businesses such as BioScience and Medical Products.

Baxter International Inc. Headquarters Address

Contact

• Address location: One Baxter Pkwy, Df2-1W Deerfield 60015-4625 United States USA
• Phone number/contact information: 224-948-2000
• Website: www.baxter.com

Subsidiaries

• Gambro
• Baxter World Trade Corporation
• Baxter India Private Ltd.
• Baxter Pharmaceutical Solutions LLC
• Baxter Polska Sp. z o.o.
• Claris Lifesciences
• Baxter Healthcare Ltd. and more.

Key People/Executives for Baxter International Inc.

Baxter International Inc. Profile/Overview

Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products. The Renal business offers a portfolio to meet the needs of patients with end-stage renal disease, or irreversible kidney disease and acute kidney injuries, including technologies and therapies for peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapy (CRRT) and additional dialysis services. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices and by patients at home under physician supervision.

Baxter International Inc. Products/Capabilities

• Baxter International Inc. provides a portfolio of a wide range of renal and hospital products. The company operates through product pipelines of two segments:

1. Hospital Products – This segment is responsible for manufacturing intravenous or IV solutions and administration sets, V nutrition products, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, Iparenteral nutrition therapies, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies.
2. Renal products – The Renal segment is responsible for the provision of products intended to treat end-stage renal disease, irreversible kidney failure, and acute kidney therapies. This segment offers products for various treatment continuums, such as technologies and therapies for peritoneal dialysis, hemodialysis, continuous renal replacement therapy, and additional dialysis services.

Pharmaceutical and biotech companies are dedicated to give quality possible product and service quality to its customers and potential ventures. International medications and pharmaceuticals together with their subsidiaries are integrated in order to deliver the demands. Mentioning one of the key players in the pharmaceutical and biotechnology industry is the AstraZeneca.

AstraZeneca plc is a pharmaceutical and bio-pharmaceutical company based on the nature of an Anglo–Swedish multination. HQ and office locations was transferred to Cambridge, England in 2013, and concentrated its R&D and AstraZeneca pipeline in the following sites: Cambridge; Gaithersburg, Maryland which is the location of MedImmune for bio-pharma work and Mölndal (near Gothenburg) in Sweden, for research on traditional chemical drugs (like diabetes drugs). Consideration as the eighth-largest drug company in the world based on sales revenue was given in the year of 2015.

AstraZeneca Headquarters Address

Contact

• Address Location: 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, UK
• Phone number: 44 20 3749 5000
• Website: http://www.astrazeneca.com

Subsidiaries

• MedImmune

MedImmune has over 120 drugs in development for conditions including lupus, COPD, asthma, and many types of cancer. Major phase III trials include.

Key People/Executives for AstraZeneca

AstraZeneca Profile/Overview

• In 1913, Astra AB was initially founded in Södertälje, Sweden, by 400 doctors and apothecaries. In 1993 Demerging of pharmaceuticals businesses and its agrochemicals and specialties businesses was done by the British chemicals company ICI, to form Zeneca Group plc. Eventually in the year of 1999 merging of Astra and Zeneca Group was commenced to form AstraZeneca plc, with its headquarters in London.
• In 2002, Irresa, a drug based in Japan, was approved as monotherapy for the condition of non-small cell lung cancer. On 3 January 2004, a management team of ZI Medical was formed by Dr. Robert Nolan, a former director of AstraZeneca.
• In July 2017, the company’s CEO Pascal Soriot said that Brexit would not affect its commitment to its current plans in the United Kingdom. However, it had slowed decision making for new investment projects waiting for post-Brexit regulatory regime to settle down.

AstraZeneca Products/Capabilities

AstraZeneca PLC is dedicated to the overall discovery, development, manufacture, and commercialization of prescription medicines for immuno oncology, cardiovascular and metabolic, respiratory, infection, gastrointestinal, and neuroscience diseases in the international market.

• Its marketed products for oncology diseases comprise the following:

• Its marketed products for cardiovascular diseases comprise the following:

• Its marketed products for metabolic diseases comprise the following:

• AstraZeneca’s marketed products for respiratory diseases comprise the following:

• AstraZeneca’s marketed products for infection diseases comprise the following:

1. Fluenz Tetra/FluMist Quadrivalent
2. Synagis

• AstraZeneca’s marketed products for neuroscience diseases comprise the following:

1. Movantik/Moventig
2. Seroquel IR
3. Seroquel XR
4. Vimovo1
5. Zomig

• AstraZeneca’s marketed products for gastrointestinal diseases comprise the following:

1. Losec/Prilosec
2. Nexium

Primary care and specialty care physicians through distributors and local representative offices are beign served by AstraZeneca. Their pipeline products include 132 projects, of which 120 are in the clinical phase of development.

Pharmaceutical companies are highly dedicated in giving quality possible product and service quality to its customers and potential ventures. World pharmaceuticals and labs are integrated in order to deliver the demands. Mentioning one of the key players in the pharmaceutical and medical industry is the Allergan.

Allergan, Plc is a multi-national pharmaceutical public limited company that focuses on dermatology, research on pharmaceuticals in the skin, contact, eye, general health, and more. This company produces branded and generic drugs, and performs research and development in the pharmaceutical sector. Initally formed on the date of February 18, 2015, before when the company formerly known as Actavis, Plc changed its name which was completed as of June 15, 2015. Actavis, Plc eventually became Actavis which now forms the AmGen division of the company.

Allergan Headquarters Address

Contact

• Clonshaugh (Business and Technology Park) B&T Coolock Dublin D17 E400, Ireland
• Phone number/customer service number: 862 261 7000
• Website: www.allergan.com

Key People/Executives for Allergan

Allergan Products

Allergan plc, is highly dedicated to develop, market, manufacture and distribute medical aesthetics, biosimilar, and over-the-counter pharmaceutical products internationally. It operates through the following categorical segments:

1. US Specialized Therapeutics
2. US General Medicine
3. International segments

• The company offers a portfolio (product pipeline) of products that provide treatment for the following:
  1. Central nervous system
  2. Gastroenterology
  3. Women’s health, cosmetic and urology
  4. Ophthalmology
  5. Neurosciences
  6. Medical aesthetics
  7. Dermatology
  8. Plastic surgery
  9. Liver disease
  10. Inflammation
  11. Metabolic syndromes
  12. Fibrosis, alzheimer’s disease.

• It is also involved in other medical developments such as:
  1. Developing ocular implants that reduce intraocular pressure associated with glaucoma
  2. Medical devices for the correction of prominent ears
  3. Intranasal neurostimulation devices, as well as other dry eye products

• In addition, the medical manufacturing company distributes tangible products such as generic and branded pharmaceutical products primarily to the following recipients or locations:
  1. Independent and chain pharmacies
  2. Nursing homes
  3. Mail order pharmacies
  4. Hospitals
  5. Clinics
  6. Physician offices

Pharmaceutical products and services are provided by companies that are dedicated to its people. Pharmaceutical companies form merges and are strategically integrated in order to deliver the demands in the international market. One of the main players in the pharmaceutical industry is the AmerisourceBergen Corporation.

AmerisourceBergen Corporation (referred to as ABC AmeriSource) is a drug company based in the USA that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. Corporate headquarters of the AmerisourceBergen group are in subsidiaries and locations (HQ) in the US, mainly in Pennsylvania. Drug distribution specialty in their distribution centers and related services designed to reduce costs and improve patient outcomes, distribute a range of brand name and generic pharmaceuticals, over-the-counter (OTC) health care products and home health care supplies and equipment to a wide variety of health care providers located throughout the United States are provided by the company. Provision of pharmaceuticals and pharmacy services to long-term care, workers’ compensation, HR portals and specialty drug patients are also practised.

AmerisourceBergen Corporation Headquarters Address

Contact

• 1300 – Morris Drive, Chesterbrook, Pennsylvania 19087, USA
• Phone number: 610-727-7000
• Website/HR Portal: www.amerisourcebergen.com

Key People/Executives for AmerisourceBergen Corporation

AmerisourceBergen Corporation Profile/OverviewC

In the year of 2001, the company was initially formed, following the merger of two existing corporations: AmeriSource Health Corporation and Bergen Brunswig Corporation. They were both successful pharmaceutical distributors that served common ventures but covered somewhat different geographies. The said corporate move gave the company a strong national presence that was utilised to the international pharmacies, regional retail chain pharmacies, hospitals and more.

The prosperous company totalled to 26 pharmaceutical distribution centers in the United States alone, nine distribution centers in Canada, four specialty distribution centers in the US, and over 1 million square feet of packaging production space in the US and the UK. Together with the added functionality of the World Courier, the largest specialty courier company in the world, increasing to more than a hundred.

AmerisourceBergen Corporation Products/Capabilities

The AmerisourceBergen Corporation sources and distributes pharmaceutical products in the international market. The company is divided into several segments:

1. Its Pharmaceutical Distribution (PD) segment distributes the following products:
   1. Brand-name and generic pharmaceuticals
   2. Over-the-counter healthcare products
   3. Home healthcare supplies and equipment
   4. Outsourced compounded sterile preparations
   5. Related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
   6. Pharmacy overall management processes, staffing, and other consulting services
   7. Supply management software to retail and institutional healthcare providers
      packaging solutions to various institutional and retail healthcare providers
   8. Pharmaceutical distribution and other services primarily to medical professionals, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics
   9. Distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products
   10. Offers third party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers.
2. The company’s Other segment is dedicated to provide commercialization support services, including the following specifics:
   1. Reimbursement support programs
   2. Outcomes research
   3. Contract field staffing
   4. Patient assistance and co-pay assistance programs
   5. Adherence programs
   6. Risk mitigation services
   7. Other market access programs to pharmaceutical and biotechnology manufacturers
   8. Specialty transportation and logistics services for the biopharmaceutical industry
   9. Animal health care products.